Kalbe Farma Tbk vs Multi Bintang Indonesia Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Multi Bintang Indonesia Tbk. trades at Rp6,325 (market cap 13.33T, 51.1K 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 2.5× Multi Bintang Indonesia Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 51.1K). Which is the better fit depends on your goals.
| KLBF | MLBI | |
|---|---|---|
Market Cap | 33T | 13.33T |
Volume | 98.44M | 51.1K |
Lot | 984.38K | 511 |
Turnover | 70.64B | 322.91M |
Average Price | 717.58 | 6,319.08 |
Value | 70.64B | 322.91M |
Indicative Equilibrium Price | 720 | — |
Indicative Equilibrium Volume | 43.62K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Multi Bintang Indonesia Tbk (The Company) was established on June 3, 1929, based on notarial deed No. 8 of Tjeerd Dijkstra, notary public in Medan, under the name of NV Nederlandsch Indische Bierbrouwerijen. The Company is part of the Heineken Group, where the ultimate shareholder is Heineken N.V. (Heineken).
Read more on MLBI →